Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance with Targeted Agents

Symposium Summary and Audience Q&A

Friday, July 1, 2022

14:55 – 15:10

Location: Rooms 111-112; Level 1

Session Chair(s)

Elena Elez, Sr., MD PhD

Vall Hebron University Hospital
Barcelona, Spain
Yelena Y. Janjigian, MD

Memorial Sloan Kettering Cancer Center
New York, United States

Supported by Daiichi